• Consensus Rating: Hold
  • Consensus Price Target: $122.22
  • Forecasted Upside: 14.74 %
  • Number of Analysts: 11
  • Breakdown:
  • 2 Sell Ratings
  • 6 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▼ -1.99 (-1.83%)

This chart shows the closing price for XYL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Xylem Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XYL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XYL

Analyst Price Target is $122.22
▲ +14.74% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Xylem in the last 3 months. The average price target is $122.22, with a high forecast of $140.00 and a low forecast of $107.00. The average price target represents a 14.74% upside from the last price of $106.52.

This chart shows the closing price for XYL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 contributing investment analysts is to hold stock in Xylem. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 13 hold ratings
  • 2 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 13 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 12 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 2 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2022Raymond JamesDowngradeMarket Perform ➝ UnderperformHigh
12/16/2021MizuhoInitiated CoverageNeutral$115.00High
11/22/2021Loop CapitalInitiated CoverageHold$120.00Medium
11/3/2021Credit Suisse GroupBoost Price TargetUnderperform$105.00 ➝ $111.00Medium
11/2/2021Boenning ScattergoodReiterated RatingNeutralHigh
10/1/2021Royal Bank of CanadaLower Price TargetOutperform$140.00 ➝ $136.00High
10/1/2021Credit Suisse GroupLower Price TargetUnderperform$110.00 ➝ $105.00High
10/1/2021Rosenblatt SecuritiesDowngradeBuy ➝ Hold$140.00 ➝ $120.00High
8/5/2021Rosenblatt SecuritiesBoost Price TargetBuy$130.00 ➝ $140.00Low
8/4/2021Credit Suisse GroupBoost Price TargetUnderperform$97.00 ➝ $110.00Medium
8/4/2021Royal Bank of CanadaBoost Price TargetOutperform$127.00 ➝ $140.00High
8/4/2021CitigroupBoost Price TargetNeutral$117.00 ➝ $131.00High
6/18/2021ArgusInitiated CoverageBuy$140.00Medium
5/5/2021Credit Suisse GroupBoost Price TargetPositive ➝ Underperform$90.00 ➝ $97.00High
5/5/2021The Goldman Sachs GroupUpgradeSell ➝ Neutral$73.00 ➝ $107.00Medium
5/5/2021Royal Bank of CanadaBoost Price TargetHold ➝ Outperform$112.00 ➝ $127.00Medium
3/31/2021Morgan StanleyInitiated CoverageOverweight$120.00Low
2/5/2021CitigroupLower Price TargetNeutral$113.00 ➝ $109.00Low
2/5/2021Credit Suisse GroupBoost Price TargetUnderperform$89.00 ➝ $90.00Medium
1/8/2021Raymond JamesDowngradeOutperform ➝ Market PerformHigh
1/8/2021CowenDowngradeMarket Perform ➝ Underperform$65.00High
12/15/2020Stifel NicolausDowngradeBuy ➝ Hold$100.00High
10/30/2020Credit Suisse GroupBoost Price TargetUnderperform$69.00 ➝ $75.00Low
10/8/2020Raymond JamesBoost Price TargetOutperform$85.00 ➝ $93.00Medium
9/13/2020Royal Bank of CanadaReiterated RatingBuyLow
7/31/2020Credit Suisse GroupBoost Price TargetUnderperform$62.00 ➝ $69.00High
7/30/2020Rosenblatt SecuritiesLower Price TargetBuy$85.00 ➝ $82.00High
7/30/2020OppenheimerReiterated RatingHoldHigh
7/27/2020Jefferies Financial GroupBoost Price TargetHold$70.00 ➝ $75.00Medium
7/14/2020OppenheimerInitiated CoverageHoldHigh
7/14/2020Rosenblatt SecuritiesUpgradeNeutral ➝ Buy$70.00 ➝ $85.00High
7/2/2020Royal Bank of CanadaReiterated RatingBuyLow
6/19/2020Robert W. BairdBoost Price TargetNeutral$71.00 ➝ $74.00High
6/4/2020OppenheimerReiterated RatingHoldHigh
6/3/2020Rosenblatt SecuritiesReiterated RatingHold$63.00 ➝ $70.00Low
6/3/2020Janney Montgomery ScottBoost Price TargetNeutral$63.00 ➝ $67.00Low
5/15/2020Vertical ResearchUpgradeSell ➝ HoldLow
5/7/2020CowenLower Price TargetMarket Perform$65.00 ➝ $50.00Low
5/6/2020Robert W. BairdBoost Price TargetNeutral$61.00 ➝ $71.00High
5/6/2020Credit Suisse GroupLower Price TargetUnderperform$59.00 ➝ $55.00Medium
5/6/2020CitigroupLower Price TargetNeutral$68.00 ➝ $66.00High
4/21/2020Stifel NicolausLower Price TargetBuy$87.00 ➝ $79.00Low
4/16/2020Vertical ResearchDowngradeHold ➝ Sell$55.00Low
4/14/2020Janney Montgomery ScottLower Price TargetNeutral$77.00 ➝ $63.00Low
4/8/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$77.00 ➝ $56.00High
4/6/2020Rosenblatt SecuritiesReiterated RatingHold$66.00Medium
4/1/2020CitigroupLower Price TargetNeutral$81.00 ➝ $68.00Low
3/31/2020Atlantic SecuritiesDowngradeOverweight ➝ Neutral$75.00Medium
3/27/2020OppenheimerDowngradeOutperform ➝ Market PerformMedium
3/26/2020Berenberg BankUpgradeSell ➝ HoldHigh
3/23/2020Boenning ScattergoodDowngradeOutperform ➝ NeutralHigh
3/10/2020Credit Suisse GroupDowngradeNeutral ➝ Underperform$79.00 ➝ $74.00Medium
2/14/2020Rosenblatt SecuritiesInitiated CoverageNeutral$92.00Low
2/14/2020CitigroupInitiated CoverageNeutral$92.00Low
2/6/2020Boenning ScattergoodReiterated RatingOutperformMedium
2/6/2020Janney Montgomery ScottDowngradeBuy ➝ Neutral$77.00High
1/20/2020Royal Bank of CanadaReiterated RatingBuy$86.00Medium
12/18/2019Royal Bank of CanadaReiterated RatingBuy$79.00Low
12/17/2019CitigroupInitiated CoverageNeutral$84.00Medium
12/5/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$90.00 ➝ $70.00Low
11/1/2019Royal Bank of CanadaSet Price TargetBuy$79.00Low
11/1/2019Credit Suisse GroupSet Price TargetHold$78.00Low
11/1/2019CfraDowngradeBuy ➝ HoldMedium
9/20/2019Jefferies Financial GroupInitiated CoverageBuy$90.00 ➝ $90.00Medium
8/2/2019Credit Suisse GroupDowngradeOutperform ➝ NeutralMedium
7/8/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Positive$85.00 ➝ $91.00High
5/14/2019CowenDowngradeOutperform ➝ Market Perform$75.00 ➝ $72.00Medium
5/3/2019Stifel NicolausLower Price TargetBuy ➝ Buy$93.00 ➝ $89.00Medium
5/3/2019Janney Montgomery ScottUpgradeNeutral ➝ Buy$86.00High
4/16/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$80.00 ➝ $93.00Low
3/29/2019Janney Montgomery ScottDowngradeBuy ➝ NeutralLow
3/22/2019Boenning ScattergoodReiterated RatingBuyHigh
2/25/2019BMO Capital MarketsReiterated RatingBuy$85.00Low
2/4/2019OppenheimerSet Price TargetBuy$80.00Low
12/19/2018Stifel NicolausUpgradeHold ➝ Buy$72.00 ➝ $75.00Medium
11/19/2018Boenning ScattergoodReiterated RatingBuy$82.00Medium
10/31/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$84.00 ➝ $82.00Low
10/31/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$86.00 ➝ $81.00Low
10/31/2018Royal Bank of CanadaReiterated RatingBuy$77.00Medium
10/30/2018OppenheimerReiterated RatingBuyMedium
10/25/2018Berenberg BankSet Price TargetSell$57.00Low
10/18/2018Vertical ResearchUpgradeSell ➝ Hold$68.00Medium
10/12/2018Credit Suisse GroupInitiated CoverageOutperform$86.00Medium
10/12/2018CowenReiterated RatingBuy$85.00Medium
10/8/2018Vertical ResearchDowngradeHold ➝ SellHigh
10/3/2018Berenberg BankInitiated CoverageSell ➝ Sell$65.00Low
9/5/2018Raymond JamesInitiated CoverageOutperform ➝ Outperform$90.00High
8/1/2018Robert W. BairdReiterated RatingHold$80.00Low
8/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$83.00 ➝ $84.00Low
8/1/2018Stifel NicolausBoost Price TargetHold ➝ Hold$75.00 ➝ $80.00High
7/31/2018OppenheimerReiterated RatingBuyHigh
5/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$86.00 ➝ $83.00Low
5/2/2018Stifel NicolausLower Price TargetHold ➝ Hold$77.00 ➝ $75.00Medium
5/1/2018OppenheimerReiterated RatingBuy$82.00Medium
5/1/2018Boenning ScattergoodReiterated RatingBuy$90.00High
3/6/2018CowenReiterated RatingBuy$80.00Medium
2/2/2018BMO Capital MarketsReiterated RatingBuy$86.00High
2/2/2018OppenheimerBoost Price TargetOutperform$82.00Low
1/26/2018BMO Capital MarketsReiterated RatingBuy$83.00Medium
1/4/2018Royal Bank of CanadaReiterated RatingBuy$80.00Low
12/15/2017Boenning ScattergoodReiterated RatingBuyHigh
11/1/2017OppenheimerBoost Price TargetOutperform$66.00 ➝ $75.00N/A
11/1/2017BMO Capital MarketsBoost Price TargetOutperform$74.00 ➝ $76.00N/A
10/31/2017OppenheimerReiterated RatingBuyN/A
10/13/2017Stifel NicolausReiterated RatingHold$63.00N/A
10/4/2017Royal Bank of CanadaReiterated RatingOutperform$64.00 ➝ $71.00N/A
10/4/2017Robert W. BairdReiterated RatingHold$67.00Low
9/21/2017CowenReiterated RatingBuy$70.00Medium
9/5/2017Boenning ScattergoodReiterated RatingOutperformMedium
9/5/2017Stifel NicolausReiterated RatingHold$63.00Medium
8/9/2017CowenReiterated RatingOutperform$60.00 ➝ $70.00Low
8/2/2017BMO Capital MarketsBoost Price TargetOutperform$60.00 ➝ $65.00Low
8/2/2017OppenheimerBoost Price TargetOutperform$60.00 ➝ $66.00Low
8/2/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$58.00 ➝ $64.00Low
8/1/2017OppenheimerReiterated RatingBuy$60.00 ➝ $66.00High
7/14/2017Stifel NicolausReiterated RatingHold$60.00Medium
7/12/2017OppenheimerBoost Price TargetOutperform$58.00 ➝ $60.00Low
7/6/2017Stifel NicolausReiterated RatingHold$52.00Low
6/21/2017BMO Capital MarketsInitiated CoverageOutperform$60.00Low
6/20/2017OppenheimerSet Price TargetBuy$58.00Low
6/7/2017Boenning ScattergoodReiterated RatingBuy$55.00High
5/26/2017Stifel NicolausReiterated RatingHold$52.00N/A
5/22/2017OppenheimerReiterated RatingBuyLow
5/15/2017BarclaysUpgradeEqual Weight ➝ Overweight$51.00 ➝ $59.00High
5/10/2017CIBCReiterated RatingBuyLow
5/9/2017OppenheimerReiterated RatingBuyLow
4/6/2017CIBCReiterated RatingBuy$58.00Low
4/5/2017OppenheimerSet Price TargetBuy$58.00Medium
3/24/2017CowenBoost Price TargetOutperform$56.00 ➝ $60.00Low
3/12/2017Royal Bank of CanadaReiterated RatingBuy$57.00Low
3/8/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$52.00High
2/3/2017Boenning ScattergoodUpgradeNeutral ➝ Outperform$55.00N/A
2/3/2017Royal Bank of CanadaBoost Price TargetOutperform$55.00 ➝ $56.00N/A
2/1/2017GabelliDowngradeBuy ➝ HoldN/A
(Data available from 1/20/2017 forward)

News Sentiment Rating

0.36 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 5 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 4 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 21 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
  • 3 very positive mentions
  • 38 positive mentions
  • 7 negative mentions
  • 2 very negative mentions
  • 3 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 7 very positive mentions
  • 24 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Current Sentiment

  • 7 very positive mentions
  • 24 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Xylem logo
Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Rye Brook, NY.
Read More

Today's Range

Now: $106.52
Low: $106.20
High: $109.95

50 Day Range

MA: $119.78
Low: $106.52
High: $130.85

52 Week Range

Now: $106.52
Low: $94.63
High: $138.78


1,268,594 shs

Average Volume

1,097,016 shs

Market Capitalization

$19.21 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Xylem?

The following equities research analysts have issued stock ratings on Xylem in the last year: Argus, Boenning Scattergood, Citigroup Inc., Credit Suisse Group AG, Loop Capital, Mizuho, Morgan Stanley, Raymond James, Rosenblatt Securities, Royal Bank of Canada, The Goldman Sachs Group, Inc., and Zacks Investment Research.
View the latest analyst ratings for XYL.

What is the current price target for Xylem?

9 Wall Street analysts have set twelve-month price targets for Xylem in the last year. Their average twelve-month price target is $122.22, suggesting a possible upside of 12.6%. Argus has the highest price target set, predicting XYL will reach $140.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $107.00 for Xylem in the next year.
View the latest price targets for XYL.

What is the current consensus analyst rating for Xylem?

Xylem currently has 2 sell ratings, 6 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XYL, but not buy more shares or sell existing shares.
View the latest ratings for XYL.

What other companies compete with Xylem?

How do I contact Xylem's investor relations team?

Xylem's physical mailing address is 1 INTERNATIONAL DRIVE, RYE BROOK NY, 10573. The industrial products company's listed phone number is (914) 323-5700 and its investor relations email address is [email protected] The official website for Xylem is www.xyleminc.com.